EP2145185A2
Multianalyte assay
Abstract
This record has no abstract on file.
Term
Projected expiry 30 April 2028.
- Priority
- Filed
- Published
- Today
- Projected expiry
25 members in 7 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 915051P | United States of America | – | |
| 91505107 | United States of America | P | |
| 2008062088 | United States of America | W |
Members25
| Document | Office | Kind | |
|---|---|---|---|
| AU2007217765A1 | Australia | A1 | |
| CA2659773A1 | Canada | A1 | |
| WO2007098184A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2008199851A1 | United States of America | A1 | |
| WO2007098184A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2684998A1 | Canada | A1 | |
| WO2009014787A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2009014787A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2009014787A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2009014787A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2145185A2This record | European Patent Office (EPO) | A2 | |
| EP2145185A4 | European Patent Office (EPO) | A4 | |
| JP2010526297A | Japan | A | |
| EP2215450A2 | European Patent Office (EPO) | A2 | |
| US2010304359A1 | United States of America | A1 | |
| US7932099B2 | United States of America | B2 | |
| EP2215450A4 | European Patent Office (EPO) | A4 | |
| US2011236879A1 | United States of America | A1 | |
| JP5214723B2 | Japan | B2 | |
| EP2215450B1 | European Patent Office (EPO) | B1 | |
| ES2433377T3 | Spain | T3 | |
| US9086408B2 | United States of America | B2 | |
| US2015323534A1 | United States of America | A1 | |
| US2016011183A1 | United States of America | A1 | |
| US9791437B2 | United States of America | B2 |
12 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Application refused (corrected)R18R | R18R | EP | |
| Application refused18R | 18R | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN REFUSEDSTAA | STAA | EP | |
| Refusal decision now finalR003 | R003 | DE | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2145185
- Application
- 88265863
Titles3
- German
- MULTIANALYT-ASSAY
- English
- MULTIANALYTE ASSAY
- French
- DOSAGE DE PLUSIEURS ANALYTES
Classification
- CPC, 6
- G01N33/54366
- G01N33/54306
- B01L3/0272
- B01L3/5023
- B01L3/5029
- G01N2333/11
- IPC, 4
- G01N33 53
- G01N33 48
- G01N33 574
- G01N35 00
Designated states38
- Contracting states, 34
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
and 10 moreShow fewer
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 4
- Albania
- Bosnia and Herzegovina
- North Macedonia
- Serbia